26 July 2007 17:39 [Source: ICIS news]
HOUSTON (ICIS news)--Dow Chemical has reviewed several proposals for mergers and acquisitions, but few have fit the company, chief executive Andrew Liveris said on Thursday.
"We will do the right deal at the right time," he said.
Many US companies have announced mergers, such as Hexion Specialty Chemicals and Huntsman, worth $10.6bn (€7.7bn), and Lyondell and Basell, worth $19bn (€14bn)
However, Dow Chemical has made relatively smaller acquisitions, the recent being Wolf Walsrode, worth €540m ($740m).
"We have the firepower to add, but we want to make sure we're disciplined when it happens," Liveris said.
The company has reviewed many deals, he said. "There are just not that many properties that make sense," Liveris said.
($1 = €0.73)For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|
|
ICIS Chemicals Confidential